Side Effect Registry Immuno-Oncology
As physicians treating cancer patients with immunotherapies, we concentrate on recognising and managing immune-related adverse events (irAEs) arising from treatments such as immune checkpoint inhibitors, CAR-T cell therapies, and bispecific antibodies. We operate the SERIO online registry in partnership with the Paul Ehrlich Institute and collaborate with interdisciplinary irAE specialists worldwide to turn real-world data into safer, more effective care for patients.
SERIO aims to help physicians manage side effects and gain better knowledge of side effects induced by immunotherapy.
Collection
Register and analyze cases of rare, complex, severe and therapy-refractory adverse reactions induced by immunotherapy
Education
Provide physicians with recommendations for the management of immune-related adverse events (irAEs)
Research
Understand irAE pathogenesis to enable prediction of adverse events
Case of the Month
Participate and document cases of rare, complex, severe and therapy-refractory side effects induced by immunotherapy
Join our team of experts for analysis of irAE
Initiate or contribute to research projects with regard to irAE